Related Experiment Video
Updated: Aug 9, 2026

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
Chemical derivatization of therapeutic proteins
R A Smith1, J M Dewdney, R Fears
1SmithKline Beecham Pharmaceuticals, Great Burgh, Epsom, Surrey, UK.
Abstract:
Despite major advances in redesigning and producing proteins through recombinant DNA technology, many therapeutic proteins are still produced by extraction from biological tissues or fluids, or from nonrecombinant microorganisms. Modification of such proteins, to improve potency and bioavailability and reduce immunogenicity, can only be carried out post-translationally by chemical-derivatization methods. Genetic- and chemical-modification methods are not mutually exclusive, however, and may be combined to optimize protein-engineering strategies, because chemical modification can introduce structural changes that are not encoded by DNA into both recombinant, and nonrecombinant proteins.
Related Concept Videos
Tagging and Fusion Proteins
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

